Amneal (AMRX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Amneal Pharmaceuticals (AMRX) reported $702.47 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 13.3$0.16 for the same period compares to $0.19 a year ago. The reported revenue represents a surprise of +1.27$693.68 million. With the consensus EPS estimate being $0.13, the EPS surprise was +23.08%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they c ...